Back
Results - Announcements
Sales rise 13.01% to Rs 1265.41 crore
Strides Pharma Science consolidated net profit rises 57.52% in the June 2026 quarter
31-Jul-2026, 02:39
Net profit of Strides Pharma Science rose 57.52% to Rs 156.91 crore in the quarter ended June 2026 as against Rs 99.61 crore during the previous quarter ended June 2025. Sales rose 13.01% to Rs 1265.41 crore in the quarter ended June 2026 as against Rs 1119.74 crore during the previous quarter ended June 2025.
Net profit of Strides Pharma Science rose 57.52% to Rs 156.91 crore in the quarter ended June 2026 as against Rs 99.61 crore during the previous quarter ended June 2025. Sales rose 13.01% to Rs 1265.41 crore in the quarter ended June 2026 as against Rs 1119.74 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 1265.41 | 1119.74 | 13 |
| OPM % | 18.06 | 19.48 | - |
| PBDT | 192.82 | 179.30 | 8 |
| PBT | 136.42 | 130.41 | 5 |
| NP | 156.91 | 99.61 | 58 |
Powered by Capital Market - Live News